Bicycle Therapeutics Statistics
Total Valuation
BCYC has a market cap or net worth of $511.48 million. The enterprise value is -$209.01 million.
Important Dates
The last earnings date was Friday, August 8, 2025, before market open.
| Earnings Date | Aug 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BCYC has 69.31 million shares outstanding. The number of shares has increased by 56.59% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 69.31M |
| Shares Change (YoY) | +56.59% |
| Shares Change (QoQ) | +0.08% |
| Owned by Insiders (%) | 1.44% |
| Owned by Institutions (%) | 41.60% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 26.37 |
| Forward PS | 13.68 |
| PB Ratio | 0.76 |
| P/TBV Ratio | 0.76 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.39, with a Debt / Equity ratio of 0.01.
| Current Ratio | 10.39 |
| Quick Ratio | 10.10 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,517.45 |
Financial Efficiency
Return on equity (ROE) is -31.42% and return on invested capital (ROIC) is -22.63%.
| Return on Equity (ROE) | -31.42% |
| Return on Assets (ROA) | -19.07% |
| Return on Invested Capital (ROIC) | -22.63% |
| Return on Capital Employed (ROCE) | -38.20% |
| Revenue Per Employee | $63,216 |
| Profits Per Employee | -$794,630 |
| Employee Count | 305 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -5.85M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -67.62% in the last 52 weeks. The beta is 1.45, so BCYC's price volatility has been higher than the market average.
| Beta (5Y) | 1.45 |
| 52-Week Price Change | -67.62% |
| 50-Day Moving Average | 7.91 |
| 200-Day Moving Average | 11.87 |
| Relative Strength Index (RSI) | 37.42 |
| Average Volume (20 Days) | 280,119 |
Short Selling Information
| Short Interest | 1.66M |
| Short Previous Month | 2.17M |
| Short % of Shares Out | 4.57% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 5.41 |
Income Statement
In the last 12 months, BCYC had revenue of $19.28 million and -$242.36 million in losses. Loss per share was -$3.50.
| Revenue | 19.28M |
| Gross Profit | -208.85M |
| Operating Income | -288.32M |
| Pretax Income | -163.02M |
| Net Income | -242.36M |
| EBITDA | -281.11M |
| EBIT | -288.32M |
| Loss Per Share | -$3.50 |
Full Income StatementBalance Sheet
The company has $721.45 million in cash and $7.20 million in debt, giving a net cash position of $714.25 million or $10.31 per share.
| Cash & Cash Equivalents | 721.45M |
| Total Debt | 7.20M |
| Net Cash | 714.25M |
| Net Cash Per Share | $10.31 |
| Equity (Book Value) | 668.92M |
| Book Value Per Share | 9.66 |
| Working Capital | 726.84M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$208.38 million and capital expenditures -$1.91 million, giving a free cash flow of -$210.29 million.
| Operating Cash Flow | -208.38M |
| Capital Expenditures | -1.91M |
| Free Cash Flow | -210.29M |
| FCF Per Share | -$3.03 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -1,495.33% |
| Pretax Margin | -1,287.33% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BCYC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -56.58% |
| Shareholder Yield | -56.58% |
| Earnings Yield | -47.97% |
| FCF Yield | -41.62% |
Analyst Forecast
The average price target for BCYC is $22.91, which is 210.43% higher than the current price. The consensus rating is "Buy".
| Price Target | $22.91 |
| Price Target Difference | 210.43% |
| Analyst Consensus | Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (5Y) | 69.30% |
| EPS Growth Forecast (5Y) | -58.92% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BCYC has an Altman Z-Score of 2.66 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.66 |
| Piotroski F-Score | 1 |